Clearway Health

What Clearway Health does

Clearway Health is a Boston-based, privately held specialty pharmacy services company that partners with hospitals and health systems to build, operate, and optimize in-house specialty pharmacy programs. Founded in 2021 as a commercial spin-out of Boston Medical Center Health System, the company extends more than a decade of operational specialty pharmacy experience — including BMCHS's growth of specialty pharmacy revenue by over $580 million in 10 years — to external provider organizations. Its service offering spans specialty pharmacy program design and development, embedded clinical staff (dedicated pharmacists and pharmacy patient liaisons placed in partner outpatient clinics), payor/PBM/LDD network access, 340B program optimization, and accreditation support (URAC, ACHC). Documented client outcomes include growing one partner's annual specialty pharmacy revenue from $19.2M to $165.4M in under 24 months, reducing prior authorization turnaround from 42 days to 1.5 days, and delivering $288M in specialty pharmacy revenue for OU Health.

The company's core technology asset is Charter, a proprietary cloud-based patient management platform launched in October 2024 and purpose-built for hospital-based specialty pharmacy programs. Charter integrates with hospital EHR systems, provides role-based workflows, automates benefits investigation and prior authorization processes, supports longitudinal patient tracking, and exposes KPI dashboards to health system leadership. The platform is SOC 2 assessed and is positioned as the operational backbone of the company's managed services engagements.

Clearway Health operates a B2B enterprise model, selling multi-year managed services partnerships to acute care hospitals, health systems, and academic medical centers (with a secondary focus on safety-net and essential hospitals). Pricing is quote-based and not publicly disclosed, and revenue derives from a mix of program management fees and value-based components tied to client revenue or savings performance. The company has signed 13 hospital and health system partners across at least five U.S. states (Massachusetts, New York, Connecticut, California, Kentucky) and employs 101-250 people, including a dedicated C-suite following the November 2025 appointment of Brandon Newman as the company's first CEO. The firm remains majority-affiliated with its founding parent, Boston Medical Center Health System.

Name

Clearway Health

Legal name

Clearway Health

Website

https://clearwayhealth.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

101–250 employees

Short description

Clearway Health partners with hospitals and health systems to build, operate, and optimize in-house specialty pharmacy programs, embedding dedicated pharmacists and pharmacy liaisons in partner clinics and supporting them with its proprietary Charter patient management platform. Founded in 2021 as a spin-out of Boston Medical Center Health System, it serves 13 provider partners across at least five U.S. states.

Ownership category

akta.pro rank

Product category

Specialty Pharmacy Services

NAICS

Ambulatory Health Care Services (621)

SIC

Services-Health Services (8000)

akta.pro primary industry

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

akta.pro secondary industries

Hospital & Health-System Pharmacies (Inpatient/Outpatient) (HLAFALAB), Pharmacy Liaison & Prior Authorization/Insurance Coordination (HSABALAD)

Keywords

• Specialty pharmacy services
• Hospital pharmacy partnerships
• Patient management software
• Pharmacy program design
• Embedded clinical pharmacists

Headquarters

HQ city

Boston

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Specialty Pharmacy Partnership Services: Clearway Health generates revenue through strategic partnerships with hospitals and health systems to build, develop, and operate specialty pharmacy programs. The model includes embedded staff services, program design, technology implementation, and ongoing operational management. Revenue is derived from helping partners unlock specialty pharmacy revenue, improve medication cost savings, and develop new clinical programs. The company reports case study results including growing one client's annual specialty pharmacy revenue from $19.2M to $165.4M in less than 24 months.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Clearway Health partners with hospitals and health systems to design, build, and operate in-house specialty pharmacy programs. The company embeds dedicated pharmacists and pharmacy patient liaisons directly into partner clinical workflows to manage specialty medication access, prior authorizations, financial assistance, and adherence. Its proprietary cloud-based patient management platform, Charter, underpins the service delivery with EHR-integrated workflows, KPI dashboards, and longitudinal patient tracking.

Product overview

Clearway Health offers a specialty pharmacy services platform anchored by its proprietary software product, Charter. The core platform is supplemented by four primary service offerings: Specialty Pharmacy Expertise/Program Design (including pharmacy opportunity analysis, design/development, data and analytics, and employee health plan pharmacy benefit design), Embedded Pharmacy Liaisons & Pharmacists (providing patient education, benefits investigation, prior authorization services, patient assistance programs, and clinical counseling), Proprietary Patient Management Software (Charter for enrollment and longitudinal patient management), Operations & Staffing Management Services (pharmacy operations optimization, fulfillment/dispensing, inventory management, and cold chain services), and Program Expansion & Clinical Programs (including 340B optimization, payor/LDD/PBM access, accreditation services such as URAC and ACHC, and contract pharmacy strategy). The Charter software enables all service delivery and provides clients with KPI insights and performance dashboards.

Differentiator

Problem solved

Functional benefit

Products and services

• Specialty Pharmacy Partnership Services End-to-end specialty pharmacy program design, build, and operational management for hospitals and health systems, including embedded pharmacists and pharmacy patient liaisons, program strategy, 340B optimization, payor and limited distribution drug network access, accreditation support (URAC, ACHC), and ongoing operational management.
• Charter Proprietary cloud-based patient management software purpose-built for hospital-based specialty pharmacy programs. Provides EHR-integrated workflows, real-time prescription and fulfillment views, role-based workflows, demographic and financial assistance documentation, KPI dashboards with week-over-week trend reporting, and a unique patient identifier that supports longitudinal tracking of patients across specified disease states.

Quantifiable outcome

• Revenue growth from $19.2M to $165.4M in under 24 months for one client
• +5 more outcomes

Named customers7 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Four partnerships are on record, tiered core and flagship.

• Med Center HealthcoreStrategic or Co-development Partner · 15 April 2026Med Center Health and Clearway Health partnered to establish a specialty pharmacy program in Bowling Green, Kentucky. The program embeds certified pharmacists and pharmacy patient liaisons into ambulatory specialty clinics to help navigate medication delivery, financial assistance, and administrative tasks. Future plans include expanding specialty pharmacy services to additional Med Center Health clinics and opening a dedicated specialty pharmacy space.
• Middlesex HospitalcoreStrategic or Co-development Partner · 1 October 2025Middlesex Hospital in Middletown, Connecticut partnered with Clearway Health to open the Middlesex Hospital Specialty Pharmacy, marking the health system's first retail and specialty pharmacy. Located in the Middlesex Health Cancer Center, the facility aims to expand access to specialty medications for outpatients across Middlesex County and the Connecticut shoreline, addressing care gaps from recent retail pharmacy closures.
• Cottage HealthcoreStrategic or Co-development Partner · 5 May 2025Cottage Health partnered with Clearway Health to launch a specialty pharmacy program at California facilities. The program integrates pharmacists and patient liaisons directly into specialty clinics to assist patients with insurance approvals, financial assistance, and prior authorizations. The program launched at Cottage Cystic Fibrosis Clinic and pediatric clinics, with plans to expand and open an outpatient retail and specialty pharmacy.
• Boston Medical Center Health SystemflagshipStrategic or Co-development PartnerClearway Health originated from Boston Medical Center Health System (BMCHS), emerging as a solution to improve access to care and manage complex medication needs. BMCHS founded Clearway Health to extend their lived experiences and partner with other hospitals and health systems. In 10 years, BMCHS grew specialty pharmacy revenue by more than $580 million.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Soleo Health: Soleo Health operates specialty infusion and pharmacy services for complex conditions, partnering with providers and patients on high-cost therapies. It is comparable to Clearway in its focus on complex, high-touch specialty medication management, though it leans more on home/site-of-care infusion.
• Shields Health Solutions: Shields Health Solutions is the closest direct competitor, partnering with hospitals and health systems to build and operate specialty pharmacy programs with embedded clinical teams and proprietary technology. Its model closely mirrors Clearway's, and it was acquired by Walgreens Boots Alliance to scale that offering nationally.
• Trellis Rx: Trellis Rx partners with health systems to operate specialty pharmacy programs, embedding pharmacists and liaisons in clinics and providing technology to manage prior authorizations, financial assistance and adherence. It is one of the most directly comparable embedded-model players to Clearway.
• CPS Solutions: CPS Solutions provides hospital pharmacy management, including specialty pharmacy build-out and embedded clinical staffing, and is a subsidiary of Optum. Clearway's newly appointed CEO previously led at CPS, making it both a direct peer and a relevant prior employer benchmark for execution capability.

Broad incumbents

• Optum Specialty Pharmacy: Optum Specialty Pharmacy operates specialty pharmacy services at national scale as part of UnitedHealth Group. It offers competing capabilities (payer access, fulfillment, embedded support) but as a broad incumbent across many provider and payer services rather than a dedicated hospital-embedded specialist.
• CVS Specialty (CVS Health): CVS Specialty, part of CVS Health, is a leading national specialty pharmacy integrated with Caremark PBM and MinuteClinic. It competes for specialty script volume and payer access and represents the broader incumbent model against which hospital-embedded players like Clearway must differentiate.
• Cardinal Health Specialty Pharmacy: Cardinal Health's specialty solutions business supports hospital and health system specialty pharmacy programs with distribution, analytics and clinical services. It competes with Clearway as a scaled distributor-plus-services incumbent rather than a dedicated embedded staffing partner.
• McKesson Specialty Health: McKesson distributes specialty pharmaceuticals and operates specialty pharmacy and patient support services for providers and manufacturers. It overlaps with Clearway on access to limited distribution drugs, fulfillment, and program services, but at far greater scale and through a wholesaler model.
• Walgreens Specialty Pharmacy: Walgreens operates one of the largest US specialty pharmacy networks, expanded through its acquisition of Shields Health Solutions. It competes with Clearway for specialty script capture and limited distribution access, but at much larger scale and through retail and central-fill models rather than embedded hospital staffing.

Emerging players

• Genoa Healthcare: Genoa Healthcare, part of UnitedHealth Group's Optum, operates pharmacies embedded within community mental health and behavioral health clinics. Its embedded pharmacy model overlaps with Clearway's in concept, but its focus on behavioral health makes it a partial/emerging peer rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/ClearwayH
• Facebookfacebook.com/ClearWayHealth1
• LinkedInlinkedin.com/company/clearwayhealth

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clearway Health